Neonmind Biosciences Inc (OP: NMDBF )

N/A UNCHANGED
Last Price Updated: 10:22 AM EST, Dec 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neonmind Biosciences Inc

< Previous 1 2 Next >
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
Via Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
NeonMind To Improve Patient Care And Data Management With Thrive Health's Digital Healthcare Platform
NeonMind Biosciences Inc. 
Via Benzinga
NeonMind To Launch 10 Mental Health Clinics In Canada, How Will Patients Benefit?
NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript... 
Via Benzinga
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 /... 
From NeonMind Biosciences Inc.
Via AccessWire
Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space
The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ... 
Via Benzinga
NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss
NeonMind Biosciences Inc. (OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) has filed a new patent application with the U.S. Patent and ... 
Via Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ... 
Via Benzinga
NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division
NeonMind Biosciences Inc.(OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) provided a summary of business highlights on the ... 
Via Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ... 
Via Benzinga
NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments
Psychedelic drug company NeonMind Biosciences Inc. (CSE:NEON)... 
Via Benzinga
Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified
Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: 
Via Benzinga
NeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health Clinic
NeonMind Biosciences Inc. (CSE:NEON)(OTCQB: 
Via Benzinga
NeonMind To Open Its First Specialty Mental Health Clinic In Ontario, More To Come
Psychedelics company NeonMind Biosciences Inc. (OTCQB:NMDBF 
Via Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... 
Via Benzinga
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
- FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for sustainable weight loss - Company plans to file an IND... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, is... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, today... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021 VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind"),... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Advances Strategy for Specialty Clinic Launch
Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF)... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind''or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces DTC Eligibility
VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
- Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity - Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman - Expands Regulatory... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.